Login / Signup
PDE5 to keep them alive: The use of phosphodiesterase type-5 inhibitors in severe pulmonary hypertension associated with interstitial lung disease.
Jason Weatherald
Marc Humbert
Published in:
Respirology (Carlton, Vic.) (2022)
Keyphrases
</>
interstitial lung disease
pulmonary hypertension
systemic sclerosis
rheumatoid arthritis
idiopathic pulmonary fibrosis
pulmonary artery
pulmonary arterial hypertension
early onset
coronary artery